Macular Degeneration: Prevention & Management

The macula is the small central area of your retina responsible for sharp, detailed vision needed for activities like reading, driving, and recognizing faces. When it becomes damaged, as in macular degeneration, central vision can blur or distort, but peripheral vision often remains intact, allowing adaptation with the right support from our team.

The two primary forms are dry and wet macular degeneration, each progressing differently and requiring tailored approaches from our retina specialists at ReFocus Eye Health Hatboro.

• Dry macular degeneration, the most common type affecting 85-90% of cases, involves gradual thinning and atrophy of the macula due to drusen buildup, leading to slow vision loss.
• Wet macular degeneration, though less common, causes rapid vision changes from abnormal blood vessel growth and leakage under the retina, often developing from the dry form.

Initial symptoms might include subtle blurring, dark spots in your central view, or wavy lines where straight ones should be, making tasks like cooking or reading challenging. At ReFocus Eye Health Hatboro, we help patients maintain independence through our general ophthalmology and low-vision support services, noting that while advanced stages can severely limit central vision, total blindness is rare and side vision usually persists.

Macular degeneration arises from a mix of genetic, environmental, and lifestyle factors that harm the macula's cells through oxidative stress, inflammation, and disrupted blood flow or cholesterol metabolism in the retina. Recent research highlights issues like faulty cholesterol processing as key contributors, which our ophthalmologists monitor during routine exams to catch early signs.

This condition mainly impacts adults over 60, with higher rates among those of Caucasian descent and with family history, though younger people can develop early forms. Serving communities in Montgomery, Bucks, Philadelphia, and Delaware Counties, our practice at ReFocus Eye Health Hatboro sees many local patients and emphasizes early screening for at-risk individuals to preserve their vision.

AREDS2 formula supplements with vitamins C and E, zinc, copper, lutein, and zeaxanthin slow progression in intermediate dry cases, but only for those at moderate to high risk. Consult our ophthalmologists before starting to ensure they fit your needs without excess.

For wet macular degeneration, anti-VEGF drugs like Eylea HD, Vabysmo, Lucentis, or Beovu injected into the eye block leaky vessels, stabilizing or improving vision with fewer visits thanks to longer-acting versions in 2025. These outpatient procedures are safe and effective, revolutionizing care at our practice.

Laser treatments seal leaks in wet cases, while photodynamic therapy uses light-activated drugs for precise targeting, though less common now with anti-VEGF advances. Emerging photobiomodulation uses non-invasive light to aid dry AMD cell repair, available through our innovative services.

Tools like magnifiers, adjustable screens, and specialized lighting help with daily tasks, and our low-vision experts provide training to enhance independence. We integrate this with oculoplastics and aesthetics for comprehensive support.

2025 brings hope with gene therapies like RGX-314 producing anti-VEGF naturally, stem cell replacements for damaged cells, complement inhibitors such as Syfovre for dry AMD's geographic atrophy, and implants like Susvimo for sustained drug release. Our team stays current on clinical trials and advanced options, discussing suitability during your visits for potential access in the Philadelphia region.